Skip to main content
. 2024 Apr 4;12(4):802. doi: 10.3390/biomedicines12040802

Figure 2.

Figure 2

Overview of the pathophysiology behind myocardial ischemia–reperfusion injury (MIRI) and potential pharmaceutical therapeutic targets.